U.S. Markets closed

Nymox Pharmaceutical Corporation (NYMX)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.10-0.07 (-1.68%)
At close: 4:00PM EDT

4.10 0.00 (0.00%)
After hours: 5:03PM EDT

People also watch
SPHSEBIOPBMDCYCCNVGN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue283.6112,761.2652,949.509
Cost of Revenue173.023160.315173.667
Gross Profit110.5882,600.952,775.842
Operating Expenses
Research Development6,797.7688,649.514,761.557
Selling General and Administrative6,182.21811,611.7442,738.99
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-12,869.398-17,660.304-4,724.705
Income from Continuing Operations
Total Other Income/Expenses Net--189.575
Earnings Before Interest and Taxes-12,869.398-17,660.304-4,535.13
Interest Expense240.21233.559110.963
Income Before Tax-13,109.608-17,893.863-4,646.093
Income Tax Expense---52
Minority Interest--400
Net Income From Continuing Ops-13,109.608-17,893.863-4,594.093
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,109.608-17,893.863-4,594.093
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,109.608-17,893.863-4,594.093